• Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Arteriovenous Malformations



Vascular Restenosis

Abdominal Aortic Aneurysms

Neurovascular dementia




Certificate: Foundations in Learning and Teaching, Macquarie University (2017)

Guest Lecturer in:

Blood Supply to the Brain (B Clin Sci)

Cell Cycle and Disease (B Clin Sci)

DNA damage and repair (B Clin Sci)

Cellular and Hormone Signalling (MD Program)

Blood supply to the CNS and the CSF system (MD program)

Cell cycle (MD program & Clinical Science year 1)

Respiratory infections (MD program)

CNS blood supply and aberrations (MD program)

Unit Convenor: Renal, Reproductive and Endocrine Systems, Sem II, 2020




Professional overview

Dr McRobb is a scientist with over 25 years of research experience in microbiology, biochemistry, cell biology, and cell signalling, with a primary focus in the area of endocrinology and vascular disease. Prior to her PhD, Dr McRobb was a senior scientist in the School of Molecular Biosciences (University of Sydney) studying the molecular mechanisms of bacterial evolution and adaptation to nutrient stress. She received her PhD in the area of vascular biology from the University of Sydney in 2008 and held postdoctoral positions at The Heart Research Institute (Sydney) and the Centre for Vascular Research (University of NSW). In 2014, Dr McRobb joined the Neurosurgery group at Macquarie (Department of Clinical Medicine) led by Professor Marcus Stoodley to study brain vascular malformations. She has been a guest lecturer in the Bachelor of Clinical Science since 2016 and in the MD program since 2018.

Areas of research interest

Dr McRobb is interested in understanding the pathogenesis of vascular disease and vascular abnormalities and using this information to develop novel treatment approaches. Her previous studies have investigated the role of androgens (male hormones) in driving atherosclerosis and vascular calcification, and the development of small molecule inhibitors for the treatment of vascular disorders such as abdominal aortic aneurysms and vascular restenosis after coronary interventions. Dr McRobb’s current research studies in the Neurosurgery group aim to develop vascular targeting agents (VTAs) for the treatment of brain arteriovenous malformations (AVMs). These are abnormal vascular structures prone to rupture, which are the leading cause of haemorrhagic stroke in children and young adults. VTA development first involves identifying novel and specific molecular targets in gamma-radiated AVMs. Pre-clinical models and proteomic analysis have been used to identify up-regulated proteins expressed on the surface of irradiated cells lining the vascular wall. Current studies aim to complete the validation of several novel molecules induced by radiation and to develop targeted drugs designed to occlude the abnormal AVM vessels and eliminate the risk of rupture and stroke. We are also aiming to establish new in vitro AVM models for the identification of novel surface biomarkers for drug delivery, imaging or bioassays.

Education/Academic qualification

Vascular Disease, PhD, University of Sydney

1 Jul 200415 Jan 2008


Dive into the research topics where Lucinda McRobb is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 7 Similar Profiles


Recent external collaboration on country level. Dive into details by clicking on the dots.
If you made any changes in Pure these will be visible here soon.